|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS: | ||||||||||||||||||||
| Cash on hand and noninterest-bearing deposits in financial institutions | ||||||||||||||||||||
| Federal funds sold and interest-bearing deposits in financial institutions | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Certificates of deposit in financial institutions | ||||||||||||||||||||
| Securities, held-to-maturity (fair value of $5,270 at March 31, 2025 and $5,530 at June 30, 2024) | ||||||||||||||||||||
| Securities, available-for-sale | ||||||||||||||||||||
| Securities, held-to-maturity (fair value in 2026 of $4,229 and 2025 of $5,026) | ||||||||||||||||||||
| Equity securities, at fair value | ||||||||||||||||||||
| Federal bank and other restricted stocks, at cost | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Total loans | ||||||||||||||||||||
| Less allowance for credit losses | ||||||||||||||||||||
| Net loans | ||||||||||||||||||||
| Cash surrender value of life insurance | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Core deposit intangible, net | ||||||||||||||||||||
| Other real estate owned and repossessed assets | ||||||||||||||||||||
| Accrued interest receivable and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES: | ||||||||||||||||||||
| Noninterest-bearing demand | ||||||||||||||||||||
| Interest bearing demand | ||||||||||||||||||||
| Savings | ||||||||||||||||||||
| Time | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Federal Home Loan Bank advances | ||||||||||||||||||||
| Accrued interest payable and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitments and contingent liabilities | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Preferred stock, no par value; 350,000 shares authorized | ||||||||||||||||||||
| Common shares, no par value; 8,500,000 shares authorized; 3,205,369 and 3,193,414 shares issued as of June 30, 2026 and June 30, 2025, respectively | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury stock, at cost (48,639 common shares at June 30, 2026 and 2025) | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity |
Loading...
